Fund Name | Location |
Alantis Seed Capital | Asturias, Gijón, Spain |
Amigo Health | Grapeview, United States, Washington |
Asendia Management | Bern, Bern, Switzerland |
Bahrain Mumtalakat Holding | Bahrain, Capital Governorate, Manama |
Black Beret Life Sciences | Houston, Texas, United States |
Break Trail Ventures | Boulder, Colorado, United States |
CM-CIC Capital Finance | France, Ile-de-France, Paris |
Cretrend Capital | Beijing, Beijing, China |
Founder Securities | Changsha, China, Jiangsu |
INCUBATE | Australia, New South Wales, Sydney |
Kaiheng Investment Management | - |
La French Tech | France, Ile-de-France, Paris |
Ministry of Economy and Innovation | - |
Nektar Therapeutics | California, San Carlos, United States |
NextLevel Management | Florida, New York, United States |
Photonics Management Corporation | - |
Potential VC | England, London, United Kingdom |
SAM Private Equity | Switzerland, Zürich, Zurich |
SIAR Capital | New York, New York, United States |
Springdale Ventures | Austin, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.